151 related articles for article (PubMed ID: 16647460)
1. Tracheal allograft transplantation in rats: the role of different immunosuppressants on preservation of respiratory epithelium.
Schrepfer S; Deuse T; Sydow K; Schäfer H; Detter C; Reichenspurner H
Transplant Proc; 2006 Apr; 38(3):741-4. PubMed ID: 16647460
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schäfer H; Detter C; Reichenspurner H
Transpl Int; 2006 Apr; 19(4):310-8. PubMed ID: 16573547
[TBL] [Abstract][Full Text] [Related]
3. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
Deuse T; Schrepfer S; Koch-Nolte F; Haddad M; Schwedhelm E; Böger R; Schäfer H; Detter C; Reichenspurner H
J Heart Lung Transplant; 2005 Nov; 24(11):1844-54. PubMed ID: 16297791
[TBL] [Abstract][Full Text] [Related]
4. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
[TBL] [Abstract][Full Text] [Related]
5. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas.
Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J
J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618
[TBL] [Abstract][Full Text] [Related]
6. Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton TR; Shorthouse R; Huang X; Reitz BA; Morris RE
Transplantation; 1997 Aug; 64(3):373-83. PubMed ID: 9275099
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
9. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
10. Respiratory epithelial expression of integrin alphaVbeta6 in chronic progressive allograft rejection.
Dosanjh A; Ikonen T; Morris R
J Heart Lung Transplant; 2004 Apr; 23(4):456-60. PubMed ID: 15063405
[TBL] [Abstract][Full Text] [Related]
11. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
Farivar AS; Woolley SM; Naidu BV; Fraga CH; Byrne K; Thomas R; Salzman AL; Szabo CS; Mulligan MS
J Heart Lung Transplant; 2004 Aug; 23(8):993-1002. PubMed ID: 15312830
[TBL] [Abstract][Full Text] [Related]
12. FR167653 reduces obliterative airway disease in rats.
Farivar AS; Mackinnon-Patterson B; Woolley S; Namkung J; Shimamoto A; Verrier ED; Mulligan MS
J Heart Lung Transplant; 2004 Aug; 23(8):985-92. PubMed ID: 15312829
[TBL] [Abstract][Full Text] [Related]
13. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
Farivar AS; Mackinnon-Patterson B; McCourtie AS; Namkung J; Ward PA; Mulligan MS
Exp Mol Pathol; 2005 Jun; 78(3):190-7. PubMed ID: 15924870
[TBL] [Abstract][Full Text] [Related]
14. A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection.
Velotta JB; Deuse T; Haddad M; Masuda E; Park G; Carroll D; Taylor V; Robbins RC; Schrepfer S
Transplantation; 2009 Mar; 87(5):653-9. PubMed ID: 19295308
[TBL] [Abstract][Full Text] [Related]
15. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I
Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477
[TBL] [Abstract][Full Text] [Related]
16. Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats.
Ikonen TS; Brazelton TR; Berry GJ; Shorthouse RS; Morris RE
Transplantation; 2000 Sep; 70(6):857-63. PubMed ID: 11014638
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts.
Fillinger J; Antus B
Exp Lung Res; 2010 Dec; 36(10):625-31. PubMed ID: 20860540
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans.
Boehler A; Chamberlain D; Kesten S; Slutsky AS; Liu M; Keshavjee S
Transplantation; 1997 Jul; 64(2):311-7. PubMed ID: 9256193
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts.
Adams BF; Berry GJ; Huang X; Shorthouse R; Brazelton T; Morris RE
Transplantation; 2000 Jun; 69(11):2260-6. PubMed ID: 10868623
[TBL] [Abstract][Full Text] [Related]
20. Complete replacement of tracheal epithelia by the host promotes spontaneous acceptance of orthotopic tracheal allografts in rats.
Ito Y; Suzuki H; Hattori Y; Muhammad BA; Takahashi T; Suzuki K; Kazui T
Transplant Proc; 2004 Oct; 36(8):2406-12. PubMed ID: 15561264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
